Former Sr. VP Corporate Development at Threshold Pharmaceuticals Inc.
Mr. Kaster has over 25 years of experience in both smaller biotechnology firms and large pharmaceutical companies. He has an impressive track record of developing effective patent and licensing strategies for important technologies and drug products. Mr. Kaster was formerly the VP Intellectual Properties at Kosan Biosciences, which had geldanamycin and epothilone anti-cancer agents in its pipeline and was acquired by Bristol-Myers Squibb in 2008. Prior to Kosan, he was the VP of Intellectual Property at Geron Corporation. Geron owns rights in telomerase and human embryonic stem cell technologies. Prior to Geron, he was Director of Intellectua ...
Source: Centrose LLC on 04/06/2007
By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Kevin R. Kaster. More specifically, you'll be able to:
Search for over 360,000 executive profiles.
Example: Kevin R. Kaster
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.